MoneyWorks4Me

Dishman Carbogen Amcis gets nod for MDR TB Medicine production in India

12 Sep 2019 Evaluate

Drug Controller General of India has approved MDR Tuberculosis (TB) Medicine Bedaquiline Fumarate (BULK) for Dishman Carbogen Amcis for production in India. The company has adequate production facility to produce required quantity of this life saving medicine.

Dishman Carbogen Amcis provides innovative solutions for the development and supply of drug substances and drug products to the pharmaceutical and biopharmaceutical industries.

Peers
Company Name CMP
Sun Pharma. Inds. 1842.00
Dr. Reddys Labs. 1161.00
Cipla 1365.00
Lupin 2096.00
Zydus Lifesciences 1119.50
View more..